Li D, Huang Z, Zhong J, Lin L, et al. Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study). BMC Cancer 2023;23:753.
PMID: 37580661